Tandem Diabetes Care (TNDM) Cash from Operations (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Cash from Operations came in at 11054000.0 in Q1 2026, up 160.48% YoY from 4243751.56 in Q1 2025, and up 12.92% on a QoQ basis from 9789000.0 in Q4 2025.
Tandem Diabetes Care (TNDM) Cash from Operations (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Cash from Operations data on file, last reported at 11054000.0 in Q1 2026.
- Quarterly Cash from Operations rose 160.48% year-over-year to 11054000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19611000.0 (up 40.65% YoY) and the FY2025 annual result came in at 9721000.0, down 140.13% from the prior year.
- Cash from Operations improved to 11054000.0 in Q1 2026, from 9789000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 26779000.0 in Q3 2024 to a low of 18326000.0 in Q1 2023.
- A 5-year average of 2600705.88 and a median of 5820000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations sank 232.8% — and 2024, when it surged 48589.09%.
- Tracing TNDM's Cash from Operations over 5 years: stood at 5820000.0 in 2022, then sank by 223.99% to 7216000.0 in 2023, then surged by 248.52% to 10717000.0 in 2024, then dropped by 8.66% to 9789000.0 in 2025, then climbed by 12.92% to 11054000.0 in 2026.
- The last three Cash from Operations figures came in at 11054000.0 (Q1 2026), 9789000.0 (Q4 2025), and 8264000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -34.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.63 Mn |
| Jun 30, 2026 | -34.63 Mn |
| Mar 31, 2026 | 11.05 Mn |
| Mar 31, 2026 | 11.05 Mn |
| Dec 31, 2025 | 9.79 Mn |
| Dec 31, 2025 | 9.79 Mn |
| Sep 30, 2025 | 8.26 Mn |
| Sep 30, 2025 | 8.26 Mn |
| Jun 30, 2025 | -9.50 Mn |
| Jun 30, 2025 | -9.50 Mn |
| Mar 31, 2025 | -18.28 Mn |
| Mar 31, 2025 | -18.28 Mn |
| Dec 31, 2024 | 10.72 Mn |
| Dec 31, 2024 | 10.72 Mn |
| Sep 30, 2024 | 26.78 Mn |
| Sep 30, 2024 | 26.78 Mn |
| Jun 30, 2024 | -5.28 Mn |
| Jun 30, 2024 | -5.28 Mn |
| Mar 31, 2024 | -8.00 Mn |
| Mar 31, 2024 | -8.00 Mn |